ABSTRACT
POSITRON EMISSION TOMOGRAPHY Introduction PET radiopharmaceuticals 2-deoxy-2-[18F]fl uoro-D-glucose Normal variants, pitfalls, artefacts, and incidental fi ndings Normal 18F-FDG PET/CT scan
CLINICAL APPLICATIONS Head and neck malignancy Normal variants Lung cancer and other thoracic tumours Thymomas Breast cancer Upper gastrointestinal malignancy Pancreatic malignancy Hepatobiliary malignancy Lymphoma Lower gastrointestinal malignancy Gynaecological cancers Genitourinary cancers Renal carcinoma Germ cell tumours Miscellaneous Skeletal imaging with 18F-fl uoride PET/CT
INTRODUCTION Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging are used in the assessment of patients with known or suspected cancers. Nuclear medicine plays a signifi cant role in the management of oncology patients, contributing to both diagnosis and follow-up. In addition to diagnostic imaging, radiopharmaceuticals are also used in the treatment of malignancy.
